These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 21069338)
1. Antitumor agent PX-12 inhibits HIF-1α protein levels through an Nrf2/PMF-1-mediated increase in spermidine/spermine acetyl transferase. Kim YH; Coon A; Baker AF; Powis G Cancer Chemother Pharmacol; 2011 Aug; 68(2):405-13. PubMed ID: 21069338 [TBL] [Abstract][Full Text] [Related]
2. Spermidine/spermine N(1)-acetyltransferase-1 binds to hypoxia-inducible factor-1alpha (HIF-1alpha) and RACK1 and promotes ubiquitination and degradation of HIF-1alpha. Baek JH; Liu YV; McDonald KR; Wesley JB; Zhang H; Semenza GL J Biol Chem; 2007 Nov; 282(46):33358-33366. PubMed ID: 17875644 [TBL] [Abstract][Full Text] [Related]
3. The thioredoxin redox inhibitors 1-methylpropyl 2-imidazolyl disulfide and pleurotin inhibit hypoxia-induced factor 1alpha and vascular endothelial growth factor formation. Welsh SJ; Williams RR; Birmingham A; Newman DJ; Kirkpatrick DL; Powis G Mol Cancer Ther; 2003 Mar; 2(3):235-43. PubMed ID: 12657718 [TBL] [Abstract][Full Text] [Related]
4. Novel thioredoxin inhibitors paradoxically increase hypoxia-inducible factor-alpha expression but decrease functional transcriptional activity, DNA binding, and degradation. Jones DT; Pugh CW; Wigfield S; Stevens MF; Harris AL Clin Cancer Res; 2006 Sep; 12(18):5384-94. PubMed ID: 17000671 [TBL] [Abstract][Full Text] [Related]
5. Effects of acute hypoxia exposure with different durations on activation of Nrf2-ARE pathway in mouse skeletal muscle. Ji W; Wang L; He S; Yan L; Li T; Wang J; Kong AT; Yu S; Zhang Y PLoS One; 2018; 13(12):e0208474. PubMed ID: 30513114 [TBL] [Abstract][Full Text] [Related]
6. Andrographolide inhibits hypoxia-induced HIF-1α-driven endothelin 1 secretion by activating Nrf2/HO-1 and promoting the expression of prolyl hydroxylases 2/3 in human endothelial cells. Lin HC; Su SL; Lu CY; Lin AH; Lin WC; Liu CS; Yang YC; Wang HM; Lii CK; Chen HW Environ Toxicol; 2017 Mar; 32(3):918-930. PubMed ID: 27297870 [TBL] [Abstract][Full Text] [Related]
7. Epidithiodiketopiperazines (ETPs) exhibit in vitro antiangiogenic and in vivo antitumor activity by disrupting the HIF-1α/p300 complex in a preclinical model of prostate cancer. Reece KM; Richardson ED; Cook KM; Campbell TJ; Pisle ST; Holly AJ; Venzon DJ; Liewehr DJ; Chau CH; Price DK; Figg WD Mol Cancer; 2014 Apr; 13():91. PubMed ID: 24775564 [TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms for the activity of PX-478, an antitumor inhibitor of the hypoxia-inducible factor-1alpha. Koh MY; Spivak-Kroizman T; Venturini S; Welsh S; Williams RR; Kirkpatrick DL; Powis G Mol Cancer Ther; 2008 Jan; 7(1):90-100. PubMed ID: 18202012 [TBL] [Abstract][Full Text] [Related]
9. The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis. Welsh SJ; Bellamy WT; Briehl MM; Powis G Cancer Res; 2002 Sep; 62(17):5089-95. PubMed ID: 12208766 [TBL] [Abstract][Full Text] [Related]
10. RACK1 competes with HSP90 for binding to HIF-1alpha and is required for O(2)-independent and HSP90 inhibitor-induced degradation of HIF-1alpha. Liu YV; Baek JH; Zhang H; Diez R; Cole RN; Semenza GL Mol Cell; 2007 Jan; 25(2):207-17. PubMed ID: 17244529 [TBL] [Abstract][Full Text] [Related]
11. Impairment of HIF-1α-mediated metabolic adaption by NRF2-silencing in breast cancer cells. Lee S; Hallis SP; Jung KA; Ryu D; Kwak MK Redox Biol; 2019 Jun; 24():101210. PubMed ID: 31078780 [TBL] [Abstract][Full Text] [Related]
12. Hypoxia inducible factor-1α inhibition produced anti-allodynia effect and suppressed inflammatory cytokine production in early stage of mouse complex regional pain syndrome model. Hsiao HT; Lin YC; Wang JC; Tsai YC; Liu YC Clin Exp Pharmacol Physiol; 2016 Mar; 43(3):355-9. PubMed ID: 26711019 [TBL] [Abstract][Full Text] [Related]
13. RACK1 vs. HSP90: competition for HIF-1 alpha degradation vs. stabilization. Liu YV; Semenza GL Cell Cycle; 2007 Mar; 6(6):656-9. PubMed ID: 17361105 [TBL] [Abstract][Full Text] [Related]
14. Calcineurin promotes hypoxia-inducible factor 1alpha expression by dephosphorylating RACK1 and blocking RACK1 dimerization. Liu YV; Hubbi ME; Pan F; McDonald KR; Mansharamani M; Cole RN; Liu JO; Semenza GL J Biol Chem; 2007 Dec; 282(51):37064-73. PubMed ID: 17965024 [TBL] [Abstract][Full Text] [Related]
15. The antitumor thioredoxin-1 inhibitor PX-12 (1-methylpropyl 2-imidazolyl disulfide) decreases thioredoxin-1 and VEGF levels in cancer patient plasma. Baker AF; Dragovich T; Tate WR; Ramanathan RK; Roe D; Hsu CH; Kirkpatrick DL; Powis G J Lab Clin Med; 2006 Feb; 147(2):83-90. PubMed ID: 16459166 [TBL] [Abstract][Full Text] [Related]
16. Kamebakaurin inhibits the expression of hypoxia-inducible factor-1α and its target genes to confer antitumor activity. Wang KS; Ma J; Mi C; Li J; Lee JJ; Jin X Oncol Rep; 2016 Apr; 35(4):2045-52. PubMed ID: 26781327 [TBL] [Abstract][Full Text] [Related]
17. Antisense-thioredoxin inhibits angiogenesis via pVHL-mediated hypoxia-inducible factor-1alpha degradation. Kim WJ; Cho H; Lee SW; Kim YJ; Kim KW Int J Oncol; 2005 Apr; 26(4):1049-52. PubMed ID: 15754001 [TBL] [Abstract][Full Text] [Related]
19. Spermidine/spermine-N1-acetyltransferase 2 is an essential component of the ubiquitin ligase complex that regulates hypoxia-inducible factor 1alpha. Baek JH; Liu YV; McDonald KR; Wesley JB; Hubbi ME; Byun H; Semenza GL J Biol Chem; 2007 Aug; 282(32):23572-80. PubMed ID: 17558023 [TBL] [Abstract][Full Text] [Related]
20. The overexpression and nuclear translocation of Trx-1 during hypoxia confers on HepG2 cells resistance to DDP, and GL-V9 reverses the resistance by suppressing the Trx-1/Ref-1 axis. Zhao L; Li W; Zhou Y; Zhang Y; Huang S; Xu X; Li Z; Guo Q Free Radic Biol Med; 2015 May; 82():29-41. PubMed ID: 25656992 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]